Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000287511

Medchemexpress LLC 2-chloro-4-((1R)-1-(4-(4-fluoro-2-oxopyridin-1(2H)-yl)phenyl)ethylamino)-N-(5-(trifluoromethyl)pyridin-2-yl)... | 871026-44-7 | MFCD22124520 | 99.0% | 547.96 | C26H25ClF3N5O3 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY1519610MG

Encompass_Preferred

TAK-285 is a potent, selective, ATP-competitive, orally active inhibitor of HER2 and EGFR (HER1) used in oncology and kinase research. It exhibits low-nanomolar potency against HER2 and EGFR, shows selectivity over related kinases, and has demonstrated antitumor activity with the ability to cross the blood-brain barrier.

  • Potent ATP-competitive inhibitor of HER2 and EGFR with low-nanomolar IC50 values.
  • Greater than 10-fold selectivity for HER1/2 compared with HER4.
  • Demonstrated antitumor activity and ability to penetrate the blood-brain barrier.
  • High purity suitable for biochemical and cellular assays.
  • Available as solid packs and as a 10 mM solution in DMSO for stock preparation.
  • Well characterized by molecular formula and molecular weight for compound verification.

Catalog No. 50-002-87511


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.